Abstract
A multifunctional theranostic nanoplatform based on nanosized graphene oxide (GO) and MnWO4 has been developed by in situ growth of MnWO4 nanoparticles onto GO surfaces in a hyperthermia polyol medium containing polyethylene glycol (PEG). In comparison with GO and MnWO4/PEG, the near infrared (NIR) absorbance of the produced GO/MnWO4/PEG nanocomposite is significantly improved, resulting in an enhanced photothermal conversion capability and a good photoacoustic (PA) imaging performance. It is worth to note that the longitudinal relaxivity r1 of GO/MnWO4/PEG reaches impressively 11.34 mM−1 s−1 in a 0.5 T magnetic field, which is significantly higher than ordinary Mn(II)-based T1 agents. In vivo magnetic resonance and PA imaging demonstrate that GO/MnWO4/PEG could serve as an efficient bimodal contrast agent to guide the cancer treatment. GO/MnWO4/PEG shows a high loading capacity for anticancer drug doxorubicin hydrochloride (DOX) by noncovalent forces, and the drug release could be triggered by lower pH value and external NIR light. Effective synergistic photothermo-chemotherapy has been performed in xenograft 4T1 tumor models after intravenous administration of GO/MnWO4/PEG/DOX. No obvious toxicity and side effect have been observed during in vivo treatment. These positive results suggest the promising application of GO/MnWO4/PEG as a versatile nanoplatform for multimodal imaging-guided cancer synergistic therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
